| Politician | Action | Description | Traded |
|---|---|---|---|
| Sell | INSULET CORPORATION CMN | Jun 16, 2026 | |
| Sell | Insulet Corporation | May 7, 2026 | |
| Sell | Insulet Corporation | Apr 29, 2026 | |
| Buy | INSULET CORPORATION CMN | Nov 15, 2024 | |
| Sell | Insulet Corporation | Apr 4, 2024 | |
| Sell | Insulet Corporation | Jan 4, 2024 | |
| Sell | Insulet Corp | Dec 22, 2023 | |
| Sell | Insulet Corporation | Jul 12, 2023 | |
| Sell | Daniel Goldman Grandchildren | Jul 12, 2023 | |
| Buy | Insulet Corporation | Apr 10, 2023 |
This page tracks congressional stock trading activity in Insulet Corporation (PODD) in the Healthcare sector. Disclosed Capitol has indexed 21 disclosed congressional trades involving PODD. Every trade is sourced from official STOCK Act financial disclosure filings — the same primary records the Senate and House are required to publish. The full trade list with politician names, transaction types, amount ranges, and disclosure dates is below, alongside cross-references to any related lobbying activity, federal contracts, and committee assignments.
As of July 2026 — Disclosed Capitol has tracked 21 disclosed congressional trades in Insulet Corporation (PODD) — 10:2 sell-heavy ratio — led by Tina Smith (D).
| Date | Politician | Party | Action | Amount |
|---|---|---|---|---|
| Jun 16, 2026 | Ro Khanna | D | Sell | $1,001 - $15,000 |
| May 7, 2026 | Tina Smith | D | Sell | $100,001 - $250,000 |
| Apr 29, 2026 | Tina Smith | D | Sell | $100,001 - $250,000 |
| Nov 15, 2024 | Ro Khanna | D | Purchase | $1,001 - $15,000 |
| Apr 4, 2024 | Tina Smith | D | Sale | $50,001 - $100,000 |
| Jan 4, 2024 | Markwayne Mullin | R | Sale | $1,001 - $15,000 |
| Dec 22, 2023 | Markwayne Mullin | R | Sale | $1,001 - $15,000 |
| Jul 12, 2023 | Daniel Goldman | D | Sale | $1,001 - $15,000 |
| Jul 12, 2023 | Daniel Goldman | D | Unknown | $1,001 - $15,000 |
| Apr 10, 2023 | Daniel Goldman | D | Buy | $1,001 - $15,000 |
Across the 21 disclosed congressional trades in Insulet Corporation (PODD), members of Congress have reported 2 buys and 10 sells. The average 30-day alpha vs. the S&P 500 is 0.00%.
For fiscal year 2025, Insulet Corporation reported revenue of $2.71B and net income of $247.1M, per SEC filings.
Most recent reported quarter: Q2 FY2026 — revenue $801.7M, net income $95.0M.
Figures come from SEC financial statement filings. The full annual and quarterly statement history is in the Financials tab above.